Q-Linea
20.90 SEK
-0.95 %
Less than 1K followers
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.95 %
-6.13 %
-23.89 %
-16.20 %
-19.37 %
-45.27 %
-97.29 %
-99.89 %
-99.77 %
Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.
Read moreMarket cap
396.04M SEK
Turnover
72.71K SEK
Revenue
11.1M
EBIT %
-1,591.8 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
30/4
2026
Interim report Q1'26
27/5
2026
General meeting '26
10/7
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
Q-linea announces FDA clearance of expanded ASTar blood testing menu
Q-Linea, Audiocast, Q1'26
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
